The GLP-1 peptide-based agents discussed above have demonstrated the potential to enhance spermatogenesis and testosterone synthesis in both preclinical and clinical studies, offering valuable insights for the development of therapeutic strategies in clinical practice
[PubMed: 2355952] 468
Common clinical manifestations of the disease include generalized dystonia, which can lead to complications such as speech disorders, mobility disorders and the occurrence of dysphagia, bradykinesia, macrocephaly, and seizures, etc
Additional insurance requirements may include participation in a structured weight loss program, nutrition counseling, exercise programs, behavioral health interventions, or regular follow-up visits
As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act